Global Synthetic Lethality-Based Drugs and Targets Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Monotherapy and Combination Therapy), By Application (Medical Research Institution, Hospital, and Clinic), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.

Industry: Healthcare
RELEASE DATE Feb 2025
REPORT ID SI7044
PAGES 250
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Product Type
      2. Market Attractiveness Analysis By Application
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Increasing demand for more concentrated and potent therapeutic alternatives.
    3. Restraints
      1. Financial difficulties and lengthy clinical trials
    4. Opportunities
      1.  Increased investment in R&D activities by manufacturers
    5. Challenges
      1. Complexities in molecular study
  6. Global Synthetic Lethality-Based Drugs and Targets Market Analysis and Projection, By Product Type
    1. Segment Overview
    2. Monotherapy
    3. Combination Therapy
  7. Global Synthetic Lethality-Based Drugs and Targets Market Analysis and Projection, By Application
    1. Segment Overview
    2. Medical Research Institution
    3. Hospital
    4. Clinics
  8. Global Synthetic Lethality-Based Drugs and Targets Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Synthetic Lethality-Based Drugs and Targets Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Synthetic Lethality-Based Drugs and Targets Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Pfizer
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   AtlasMedx
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Chordia Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   IDEAYA Biosciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Mission Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Repare Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Sierra Oncology
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. SyntheX Labs
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  AbbVie
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  BeiGene
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Clovis Oncology
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  GlaxoSmithKline
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Tango Therapeutics
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. MEDIC Life Sciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    16. Aprea Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    17. Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  2. Global Monotherapy, Synthetic Lethality-Based Drugs and Targets Market, By Region, 2024-2034(USD Billion)
  3. Global Combination Therapy, Synthetic Lethality-Based Drugs and Targets Market, By Region, 2024-2034(USD Billion)
  4. Global Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  5. Global Medical Research Institution, Synthetic Lethality-Based Drugs and Targets Market, By Region, 2024-2034(USD Billion)
  6. Global Hospital, Synthetic Lethality-Based Drugs and Targets Market, By Region, 2024-2034(USD Billion)
  7. Global Clinic, Synthetic Lethality-Based Drugs and Targets Market, By Region, 2024-2034(USD Billion)
  8. North America Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  9. North America Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  10. U.S.  Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  11. U.S.  Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  12. Canada Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  13. Canada Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  14. Mexico Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  15. Mexico Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  16. Europe Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  17. Europe Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  18. Germany Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  19. Germany Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  20. France Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  21. France Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  22. U.K.  Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  23. U.K.  Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  24. Italy Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  25. Italy Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  26. Spain Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  27. Spain Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  28. Asia Pacific Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  29. Asia Pacific Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  30. Japan Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  31. Japan Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  32. China Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  33. China Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  34. India Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  35. India Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  36. South America Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  37. South America Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  38. Brazil Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  39. Brazil Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  40. The Middle East and Africa Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD   Billion)
  41. The Middle East and Africa Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD   Billion)
  42. UAE Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  43. UAE Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)
  44. South Africa Synthetic Lethality-Based Drugs and Targets Market, By Product Type, 2024-2034(USD Billion)
  45. South Africa Synthetic Lethality-Based Drugs and Targets Market, By Application, 2024-2034(USD Billion)

 

  1. List of Figures 
  1. Global Synthetic Lethality-Based Drugs and Targets Market Segmentation
  2. Synthetic Lethality-Based Drugs and Targets Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Synthetic Lethality-Based Drugs and Targets Market
  9. Top Winning Strategies, 2024-2034
  10. Top Winning Strategies, By Development, 2024-2034(%)
  11. Top Winning Strategies, By Company, 2024-2034
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Synthetic Lethality-Based Drugs and Targets Market
  20. Synthetic Lethality-Based Drugs and Targets Market Segmentation, By Product Type
  21. Synthetic Lethality-Based Drugs and Targets Market For Monotherapy, By Region, 2024-2034 ($ Billion)
  22.  Synthetic Lethality-Based Drugs and Targets Market For Combination Therapy, By Region, 2024-2034 ($ Billion)
  23.  Synthetic Lethality-Based Drugs and Targets Market Segmentation, By Application
  24.  Synthetic Lethality-Based Drugs and Targets Market For Medical Research Institutions, By Region, 2024-2034 ($ Billion)
  25.  Synthetic Lethality-Based Drugs and Targets Market For Hospital, By Region, 2024-2034 ($ Billion)
  26. Synthetic Lethality-Based Drugs and Targets Market For Clinic, By Region, 2024-2034 ($ Billion)
  27. Pfizer: Net Sales, 2024-2034 ($ Billion)
  28. Pfizer: Revenue Share, By Segment, 2024 (%)
  29. Pfizer: Revenue Share, By Region, 2024 (%)
  30. AtlasMedx: Net Sales, 2024-2034 ($ Billion)
  31. AtlasMedx: Revenue Share, By Segment, 2024 (%)
  32. AtlasMedx: Revenue Share, By Region, 2024 (%)
  33. Chordia Therapeutics: Net Sales, 2024-2034 ($ Billion)
  34. Chordia Therapeutics: Revenue Share, By Segment, 2024 (%)
  35. Chordia Therapeutics: Revenue Share, By Region, 2024 (%)
  36. IDEAYA Biosciences: Net Sales, 2024-2034 ($ Billion)
  37. IDEAYA Biosciences: Revenue Share, By Segment, 2024 (%)
  38. IDEAYA Biosciences: Revenue Share, By Region, 2024 (%)
  39. Mission Therapeutics: Net Sales, 2024-2034 ($ Billion)
  40. Mission Therapeutics: Revenue Share, By Segment, 2024 (%)
  41. Mission Therapeutics: Revenue Share, By Region, 2024 (%)
  42. Repare Therapeutics: Net Sales, 2024-2034 ($ Billion)
  43. Repare Therapeutics: Revenue Share, By Segment, 2024 (%)
  44. Repare Therapeutics: Revenue Share, By Region, 2024 (%)
  45. Sierra Oncology: Net Sales, 2024-2034 ($ Billion)
  46. Sierra Oncology: Revenue Share, By Segment, 2024 (%)
  47. Sierra Oncology: Revenue Share, By Region, 2024 (%)
  48. SyntheX Labs: Net Sales, 2024-2034 ($ Billion)
  49. SyntheX Labs: Revenue Share, By Segment, 2024 (%)
  50. SyntheX Labs: Revenue Share, By Region, 2024 (%)
  51. AbbVie.: Net Sales, 2024-2034 ($ Billion)
  52. AbbVie.: Revenue Share, By Segment, 2024 (%)
  53. AbbVie.: Revenue Share, By Region, 2024 (%)
  54. AstraZeneca: Net Sales, 2024-2034 ($ Billion)
  55. AstraZeneca: Revenue Share, By Segment, 2024 (%)
  56. AstraZeneca: Revenue Share, By Region, 2024 (%)
  57. BeiGene: Net Sales, 2024-2034 ($ Billion)
  58. BeiGene: Revenue Share, By Segment, 2024 (%)
  59. BeiGene: Revenue Share, By Region, 2024 (%)
  60. Clovis Oncology: Net Sales, 2024-2034 ($ Billion)
  61. Clovis Oncology: Revenue Share, By Segment, 2024 (%)
  62. Clovis Oncology: Revenue Share, By Region, 2024 (%)
  63. GlaxoSmithKline: Net Sales, 2024-2034 ($ Billion)
  64. GlaxoSmithKline: Revenue Share, By Segment, 2024 (%)
  65. GlaxoSmithKline: Revenue Share, By Region, 2024 (%)
  66. Tango Therapeutics: Net Sales, 2024-2034 ($ Billion)
  67. Tango Therapeutics: Revenue Share, By Segment, 2024 (%)
  68. Tango Therapeutics: Revenue Share, By Region, 2024 (%)
  69. MEDiC Life Sciences: Net Sales, 2024-2034 ($ Billion)
  70. MEDiC Life Sciences: Revenue Share, By Segment, 2024 (%)
  71. MEDiC Life Sciences: Revenue Share, By Region, 2024 (%)
  72. Aprea Therapeutics: Net Sales, 2024-2034 ($ Billion)
  73. Aprea Therapeutics: Revenue Share, By Segment, 2024 (%)
  74. Aprea Therapeutics: Revenue Share, By Region, 2024 (%)
  75. Others: Net Sales, 2024-2034 ($ Billion)
  76. Others: Revenue Share, By Segment, 2024 (%)
  77. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:125
Pages:250
Countries covered:17
Companies covered::20
Forecast CAGR:15.09%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies